|
HY-14609A-250mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-10mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-100mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-5mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-50mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-1mL
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12660-10mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-2mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-5mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-50mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-1mL
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-132161-1mg
|
MedChemexpress LLC
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT [CAS 2378428-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-132161-5mg
|
MedChemexpress LLC
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT [CAS 2378428-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12862-10mg
|
MedChemexpress LLC
|
Mps1-IN-7 [CAS 1578244-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12862-100mg
|
MedChemexpress LLC
|
Mps1-IN-7 [CAS 1578244-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12862-25mg
|
MedChemexpress LLC
|
Mps1-IN-7 [CAS 1578244-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12862-5mg
|
MedChemexpress LLC
|
Mps1-IN-7 [CAS 1578244-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12862-50mg
|
MedChemexpress LLC
|
Mps1-IN-7 [CAS 1578244-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-124295-10mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-100mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-25mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-5mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-50mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-145191-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145191-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
